Baclofen 巴氯芬

CAS 1134-47-0 MFCD00055143

化学结构图

1134-47-0
SMILES: NCC(CC(=O)O)c1ccc(Cl)cc1

化学属性

Mol. FormulaC10H12ClNO2
Mol. Weight214
Melting Point208-210°C
Solubility1 M HCl: 50 mg/mL
Appearance solid

别名和识别编码

Chemical NameBaclofen
CAS Number1134-47-0
Alfabeta NameAMINOCHLOROPHENYLBUTANOICACID 434()----
MDL NumberMFCD00055143
Synonym (±)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid Lioresal (±)-Baclofen (±)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid (±)-β-(Aminomethyl)-4-chlorobenzenepropanoic acid Lioresal (+/-)-BACLOFEN (+/-)-BETA-(AMINOETHYL)-4-CHLOROBENZENEPROPANOIC ACID (+/-)-BETA-(AMINOMETHYL)-4-CHLOROBENZENEPROPANOIC ACID (RS) (RS)-BACLOFEN -(Aminomethyl)-4-chlorobenzenpropanoicacid 4-AMINO-3(4-CHLOROPHENYL)BUTYRIC ACID 4-AMINO-3-[4-CHLOROPHENYL]BUTANOIC ACID ?-(4-Chlorophenyl)-GABA ?-(Aminomethyl)-4-chloro-benzenepropanoic Acid ?-(Aminomethyl)-p-chlorohydrocinnamic Acid AURORA KA-6748 BACLOFEN Ba-34647 Baclon Benzenepropanoic acid, beta-(aminomethyl)-4-chloro- C 34 Ciba 34,647-Ba Clofen LIORESAL Lioresal beta-(4-Chlorophenyl)gaba beta-(4-chlorophenyl)gaba beta-(Aminomethyl)-4-chlorobenzenepropanoic acid beta-(Aminomethyl)-4-chlorobenzenepropanoic acid; Lioresal beta-(Aminomethyl)-p-chlorohydrocinnamic acid beta-(aminomethyl)-4-chloro-benzenepropanoicaci beta-(aminomethyl)-p-chloro-hydrocinnamicaci beta-(aminomethyl)-p-chlorohydrocinnamicacid beta-(p-Chlorophenyl)-gamma-aminobutyric acid beta-(p-chlorophenyl)-gamma-aminobutyricacid c34647ba gamma-Amino-beta-(p-chlorophenyl)butyric acid {} {} {Che β-(对氯苯基)-γ-氨基丁酸 力奥来素 巴氯芬 巴洛芬 氯 氯苯氨酪酸 氯苯氨酯酸 脊舒锭 贝康酚和路行氯苯氨丁酸
PubChem Substance ID2284
EC Number214-486-9
Reaxys-RN2104494
Merck Number937
Chemical Name Translation巴氯芬
Wiswesser Line NotationZ1YR DG&1VQ
Beilstein Registry Number2104494
LabNetwork Molecule IDLN00165349
InChIInChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Agonists, B, Bioactive Small Molecules,
  • {SNA} Agonists, B, GABAergics, Neuroscience, Neurotransmission, Neurotransmitters, 生物活性小分子, 细胞信号转导和神经科学, 细胞生物学
  • {SNA} Agonists, GABAergics, Neuroscience, Neurotransmission, Neurotransmitters, 细胞信号转导和神经科学, 细胞生物学
  • {SNA} Agonists,
  • {SNA} Agonists, B, Bioactive Small Molecules, Cell Biology, Cell Signaling and Neuroscience, GABAergics, Neuroscience, Neurotransmission,

产品应用

  • Specific GABA-B receptor agonist. Muscle relaxant (skeletal).

相关文献及参考

  • Ahuja, S., et al.: Anal. Profiles Drug Subs., 14, 527 (1985),
  • Merck 14 ,937

安全信息

Warnings IRRITANT
GHS Symbol
WGK Germany3
Hazard Codes T,Xn T
Hazard statements
  • H301 Toxic if swallowed 吞食有毒
  • H315 Causes skin irritation 会刺激皮肤
  • H317 May cause an allergic skin reaction 可能导致皮肤过敏
  • H334 May cause allergy or asthma symptoms or breathing difficulties if inhaled 吸入可能导致过敏或哮喘症状或呼吸困难
  • H335 May cause respiratory irritation 可能导致呼吸道刺激
  • H319 Causes serious eye irritation 严重刺激眼睛
  • H360 May damage fertility or the unborn child 可能对生育能力或未出生婴儿造成伤害
Personal Protective Equipment Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
RTECSMW5084200
Precautionary statements
  • P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P301+P310
  • P308+P313
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P305+P351+P338
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
  • P302+P352+P333+P313+P362+P364
  • P302+P350
  • P337+P313
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P284 Wear respiratory protection.? 佩戴呼吸保护装置。
  • P342+P311
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P285 In case of inadequate ventilation wear respiratory protection. 在通风不足的情况下,戴呼吸防护。
Signal word Danger {} {} {} {} {TCI}
UN Number UN 2811 6.1/PG 3 2811
Safety Statements
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
  • S36/37/39 Wear suitable protective clothing, gloves and eye/face protection 穿戴适当的防护服、手套和眼睛/面保护;
  • S22 Do not breathe dust 不要吸入粉尘;
  • S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
  • S26 In case of contact with eyes, rinse immediately with plenty of water and seek medical advice 眼睛接触后,立即用大量水冲洗并征求医生意见;
  • S36 Wear suitable protective clothing 穿戴适当的防护服;
  • S52 Not recommended for interior use on large surface areas 建议不在表面积大的区域内部使用;
Risk Statements
  • R42/43
  • R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
  • R61 May cause harm to the unborn child 可能对未出生的婴儿导致伤害
  • R25 Toxic if swallowed 吞咽有毒
  • R20/21/22 Harmful by inhalation, in contact with skin and if swallowed 吸入、皮肤接触和不慎吞咽有害
Packing GroupIII
Hazard Class6.1
Storage condition 2-8°C
TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 200 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NIIRDN Drugs in Japan (Ethical Drugs).  (Yakugyo Jiho Co., Ltd., Tokyo,
   Japan)  Volume(issue)/page/year: 6,576,1982

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Human - man
DOSE/DURATION           : 3429 mg/kg
TOXIC EFFECTS :
   Behavioral - coma
   Cardiac - pulse rate increase, without fall in

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 78 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   IYKEDH Iyakuhin Kenkyu.  Study of Medical Supplies.  (Nippon Koteisho
   Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, Tokyo 150, Japan)  V.1- 1970- 
   Volume(issue)/page/year: 11,181,1980

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 145 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NIIRDN Drugs in Japan (Ethical Drugs).  (Yakugyo Jiho Co., Ltd., Tokyo,
   Japan)  Volume(issue)/page/year: 6,576,1982

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 115 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   IYKEDH Iyakuhin Kenkyu.  Study of Medical Supplies.  (Nippon Koteisho
   Kyokai, 12-15, 2-chome, Shibuya, Shibuya-ku, T

其他信息

  • 储运特性:通风低温干燥; 与库房食品原料分开存放
  • color:white to very faintly yellow
  • 毒性分级:高毒
  • EPA Substance Registry System:1134-47-0(EPA Substance)
  • 急性毒性:口服-大鼠 LD50; 145 毫克/公斤; 口服-小鼠 LD50: 200 毫克/公斤
  • 药物作用:巴氯芬(1134-47-0)为解痉药,是γ-氨基丁酸(GABA)的衍生物,为作用于脊髓的骨骼肌松驰剂、镇静剂。 巴氯芬(1134-47-0)用于缓解由以下疾病引起的骨骼肌痉挛:多发性硬化、脊髓空洞症、脊髓肿瘤、横贯性脊髓炎、脊髓外伤和运动神经元病、脑血管病、脑性瘫痪、脑膜炎、颅脑外伤。
  • 巴氯芬价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2014/06/02 B3343 巴氯芬 Baclofen 5G 1420元 2014/06/02 B3343 巴氯芬 Baclofen 25G 5010元
  • 上游原料:氯苯 --> 4-氯苯甲醛 --> 乙酰氧基乙酸 --> 戊二酸 --> 戌二酸酐 --> 二乙酰乙酸乙酯
  • 可燃性危险特性:可燃; 燃烧产生有毒氮氧化物和氯化物烟雾; 患者服用副作用:血压低,脉搏降低,肌肉无力
  • MOL 文件:1134-47-0.mol
  • 灭火剂:干粉,泡沫,沙土,二氧化碳, 雾状水
  • 类别:有毒物品
  • 方法一:将对氯苯甲醛与乙酰乙酸乙酯缩合生成对氯代苯亚甲基-双-乙酰乙酸乙酯。加热水水解得对氯代苯基戊二酸。用乙酐脱水环合生成对氯代苯基戊二酸酐。再用浓氨水胺化生成对氯代苯基戊二酸亚酰胺,最后开环、降解得对氯苯氨酪酸。其最后开环、降解的具体操作方法如下:将42.25gβ-(对氯苯基)戊二酸亚酰胺在搅拌下加入到含8.32g氢氧化钠的200ml水溶液中。混合物于50℃加热10min,冷却至10-15℃,滴加含40.9g氢氧化钠的200ml水溶液,20min后,加38.8g溴,在20-25℃搅拌8h,用浓盐酸仔细地将反应液的pH值调至7,随后即沉降出细的β-(对氯苯基)-γ-氨基-丁酸结晶,再由水中重结晶,熔点206-208℃。
  • 用途一:该品系作用于脊椎的骨骼肌松驰剂,镇痉剂。适用于多发性硬化的骨骼股痉挛症;脊髓感染,变性的肌肉痉挛症;脊髓外伤性、赘生性肌肉痉挛症。
  • 外观:白色晶体粉末.

系列性分类


相关产品推荐